NCT06142253

Brief Summary

This two-year study will evaluate the feasibility and safety of an exercise + cognitive training program to improve neurological symptoms of long-COVID. This is a two-phased trial: 1) an exercise phase and 2) a cognitive training phase. The exercise phase will be an aquatic based exercise program. A combination exercise + memory training programs designed for persons with cognitive impairment have significantly improved memory more than other single intervention groups (exercise only, cognitive training only) and given the success of combination training programs with healthy adults, it is important to adapt these programs for persons with neurological symptoms of long-COVID.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Dec 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Dec 2024Dec 2026

First Submitted

Initial submission to the registry

November 17, 2023

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 21, 2023

Completed
1 year until next milestone

Study Start

First participant enrolled

December 1, 2024

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

January 28, 2025

Status Verified

January 1, 2025

Enrollment Period

2.1 years

First QC Date

November 17, 2023

Last Update Submit

January 27, 2025

Conditions

Keywords

Post-Acute COVID-19 SyndromeCognitive TrainingExerciseVeteransMental Fatigue

Outcome Measures

Primary Outcomes (1)

  • Feasibility of Intervention Measure

    The FIM is a brief measure of the feasibility of an intervention.

    At the end of study completion, an average of 8 months

Secondary Outcomes (13)

  • Acceptability of Intervention Measure

    At the end of study completion, an average of 8 months

  • Change in Fatigue Severity Scale

    Through study completion, an average of 8 months

  • Change in Mental Fatigue Scale

    Through study completion, an average of 8 months

  • Change in Digit Span

    Through study completion, an average of 8 months

  • Change in Digit Symbol Substitution Test

    Through study completion, an average of 8 months

  • +8 more secondary outcomes

Study Arms (2)

WATER+CT

EXPERIMENTAL

This is 8-month long two phase intervention consisting of: 1) 6 months of aquatic exercise followed by 2) 2 months of cognitive training.

Behavioral: WATER+CT

Usual Care

OTHER

This arm consists of psychoeducation regarding brain health and healthy lifestyles.

Behavioral: Usual Care

Interventions

WATER+CTBEHAVIORAL

This is an 8-month long two phase intervention. The first phase consists of 6 months of thrice weekly pool-based exercise occurring at VA Palo Alto. After completion of the 6 month long pool based exercise, participants transition to ten sessions of cognitive training that will occur over 2 months at the VA Palo Alto.

WATER+CT
Usual CareBEHAVIORAL

This condition involves receipt of educational materials about brain health and healthy lifestyles as well as regular contact with study staff.

Usual Care

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Veterans, age 18 to 89, of any racial or ethnic group
  • Previous COVID-19 infection at least 6 months after diagnosis documented in clinical record
  • Persistent neurological symptoms (e.g., "brain fog", cognitive impairment) occurring within 3 months of onset of COVID-19 infection and lasting at least 8 weeks in duration
  • Visual and auditory acuity to allow neuropsychological testing
  • Willingness to participate in clinical trial for 8 months
  • Approval by Primary Care Provider to participate in water-based physical exercise

You may not qualify if:

  • History of neurological (e.g., multiple sclerosis, seizure disorder, stroke,) neurodegenerative (e.g., Parkinson's disease, Alzheimer's disease) or system illness affecting CNS function (e.g., liver failure, kidney failure, congestive heart failure, systemic cancer) occurring before COVID-19 diagnosis
  • Current severe cardiac disease (e.g., uncontrolled atrial fibrillation, defined as mean 24 hour heart rate \>85 beats/min, or 24 hour maximal ventricular rate \>150 beats/min; uncontrolled ventricular arrhythmias, defined as recurrent ventricular tachycardia \>3 beats in succession, or 24 hour PVC count \>20%; active pericarditis or myocarditis; Class III/IV heart failure and / or ejection fraction \< 20%; thrombophlebitis; pulmonary disease with a drop in O2 Sat with exercise to 90% without oxygen; embolism within past 6 months)
  • Inability to participate in an exercise stress test
  • Inability to read, verbalize understanding and voluntarily sign the Informed Consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Palo Alto Health Care System, Palo Alto, CA

Palo Alto, California, 94304-1207, United States

RECRUITING

MeSH Terms

Conditions

Post-Acute COVID-19 SyndromeMotor ActivityMental Fatigue

Condition Hierarchy (Ancestors)

COVID-19Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesPost-Infectious DisordersChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehaviorFatigueSigns and SymptomsBehavioral Symptoms

Study Officials

  • Jennifer Kaci Fairchild, PhD

    VA Palo Alto Health Care System, Palo Alto, CA

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jennifer K Fairchild, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcomes assessors will be blinded to study allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Eligible participants will be randomly assigned to one of two groups: 1) Usual Care or 2) WATER+CT
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 17, 2023

First Posted

November 21, 2023

Study Start

December 1, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

January 28, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations